Oregon · 2025 Regular Session · Bill
HB 2117: Relating to tax treatment of research expenditures; prescribing an effective date.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 2117 is a bill introduced in the Oregon House on January 13, 2025. According to its official title, it concerns: Relating to tax treatment of research expenditures; prescribing an effective date. Primary sponsor: Werner Reschke (Republican). Most recent recorded action (June 28, 2025): In committee upon adjournment.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Restores the corporate excise tax credit allowed for qualified research activities at an increased maximum amount. Provides for refundability and transferability of the credit. Allows the option for research and development expenditures to be fully deducted in the tax year paid or incurred, rather than treated as capital expenditures and amortized over five years. Applies to tax years beginning on or after January 1, 2025, and before January 1, 2031. Takes effect on the 91st day following adjournment sine die.
Sponsors
Sponsors by party (alphabetical): Republican 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Werner Reschke | Primary sponsor | Republican | House | 55 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- In committee upon adjournment.
- Referred to Revenue.
- First reading. Referred to Speaker's desk.